Daily Archives :

Wednesday, May 15, 2024

May 15, 2024

Leveraging ICH Q14 for Analytical Development

What’s new with the ICH Q14 for Analytical development?To regulate drug production, there are a multitude of documents that pharmaceutical companies can refer

https://anemocyte.com/wp-content/uploads/2024/04/AMC_News_ICHQ14-1.jpg 1200 900 Anemocyte Anemocyte https://anemocyte.com/wp-content/uploads/2024/04/AMC_News_ICHQ14-1.jpg May 15, 2024 May 27, 2024

May 15, 2024

ISCT

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to ISCT 2024 in Vancouver

https://anemocyte.com/wp-content/uploads/2024/03/AMC_News_ISCT-2024-–-3@2x.jpg 2400 1800 Anemocyte Anemocyte https://anemocyte.com/wp-content/uploads/2024/03/AMC_News_ISCT-2024-–-3@2x.jpg May 15, 2024 May 27, 2024

Anemocyte S.p.A Single Shareholder Private Limited-Liability Company
Via R. Lepetit, 34 21040 Gerenzano (VA) Italy | Ph: +39 02 99372311 – Fax: +39 02 99372313 | VAT number: 12914940155 | Share capital € 530.000,00 fully paid | R.E.A. 276961

Privacy & cookie Policy